Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Rosenquist

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
Haematologica|October 3, 2019
p66Shc deficiency sets the scene for clinically aggressive chronic lymphocytic leukemiaRichard Rosenquist
Blood Advances|December 12, 2023
Time to include IGLV3-21R110 status in CLL prognostication?Richard Rosenquist
Blood|December 9, 2021
The more complex, the worse outcome in CLLRichard Rosenquist
Leukemia & Lymphoma|July 3, 2015
A new piece to the stereotypy "puzzle" in chronic lymphocytic leukemiaRichard Rosenquist
Hematological Oncology|June 9, 2021
Molecular diagnostics and reporting in lymphoid malignancies: Current status and beyondRichard Rosenquist
Blood|April 25, 2024
New signature predicts MBL-to-CLL progressionRichard Rosenquist
Blood|May 22, 2025
Chromatin dynamics in CLL: a matter of balanceRichard Rosenquist
Cancer Cell|November 16, 2016
Unraveling the DNA Methylome in Mantle Cell Lymphoma: New Insights into the Cellular OriginLarry Mansouri, Richard Rosenquist
Seminars in Cancer Biology|August 23, 2016
B-cell malignancies: All roads lead to NF-κB activationRichard Rosenquist, Kostas Stamatopoulos
Blood|December 1, 2018
Not so lost in translation: <i>RPS15</i> mutations in CLLViktor Ljungström, Richard Rosenquist
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
Haematologica|October 3, 2019
p66Shc deficiency sets the scene for clinically aggressive chronic lymphocytic leukemiaRichard Rosenquist
Blood Advances|December 12, 2023
Time to include IGLV3-21R110 status in CLL prognostication?Richard Rosenquist
Blood|December 9, 2021
The more complex, the worse outcome in CLLRichard Rosenquist
Leukemia & Lymphoma|July 3, 2015
A new piece to the stereotypy "puzzle" in chronic lymphocytic leukemiaRichard Rosenquist
Hematological Oncology|June 9, 2021
Molecular diagnostics and reporting in lymphoid malignancies: Current status and beyondRichard Rosenquist
Blood|April 25, 2024
New signature predicts MBL-to-CLL progressionRichard Rosenquist
Blood|May 22, 2025
Chromatin dynamics in CLL: a matter of balanceRichard Rosenquist
Cancer Cell|November 16, 2016
Unraveling the DNA Methylome in Mantle Cell Lymphoma: New Insights into the Cellular OriginLarry Mansouri, Richard Rosenquist
Seminars in Cancer Biology|August 23, 2016
B-cell malignancies: All roads lead to NF-κB activationRichard Rosenquist, Kostas Stamatopoulos
Blood|December 1, 2018
Not so lost in translation: <i>RPS15</i> mutations in CLLViktor Ljungström, Richard Rosenquist
Pageof 33